A Multicenter, Randomized Trial of the Inhibitory Effect of NSAIDs for APR in Primary Osteoporosis Patients Administered Zoledronic Acid
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Oct 2017
At a glance
- Drugs Zoledronic acid (Primary) ; Loxoprofen
- Indications Osteoporosis
- Focus Adverse reactions
- 23 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Sep 2017 Planned End Date changed from 7 Oct 2017 to 7 Nov 2017.
- 14 Mar 2017 New trial record